Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 187

1.

Validation of a cell-based ELISA as a screening tool identifying anti-alphavirus small-molecule inhibitors.

Spurgers KB, Hurt CR, Cohen JW, Eccelston LT, Lind CM, Lingappa VR, Glass PJ.

J Virol Methods. 2013 Oct;193(1):226-31. doi: 10.1016/j.jviromet.2013.06.007. Epub 2013 Jun 10.

PMID:
23764417
2.

Combined alphavirus replicon particle vaccine induces durable and cross-protective immune responses against equine encephalitis viruses.

Reed DS, Glass PJ, Bakken RR, Barth JF, Lind CM, da Silva L, Hart MK, Rayner J, Alterson K, Custer M, Dudek J, Owens G, Kamrud KI, Parker MD, Smith J.

J Virol. 2014 Oct;88(20):12077-86. doi: 10.1128/JVI.01406-14. Epub 2014 Aug 13.

3.

Discovery of a novel compound with anti-venezuelan equine encephalitis virus activity that targets the nonstructural protein 2.

Chung DH, Jonsson CB, Tower NA, Chu YK, Sahin E, Golden JE, Noah JW, Schroeder CE, Sotsky JB, Sosa MI, Cramer DE, McKellip SN, Rasmussen L, White EL, Schmaljohn CS, Julander JG, Smith JM, Filone CM, Connor JH, Sakurai Y, Davey RA.

PLoS Pathog. 2014 Jun 26;10(6):e1004213. doi: 10.1371/journal.ppat.1004213. eCollection 2014 Jun.

4.

Assessment of plaque assay methods for alphaviruses.

Juarez D, Long KC, Aguilar P, Kochel TJ, Halsey ES.

J Virol Methods. 2013 Jan;187(1):185-9. doi: 10.1016/j.jviromet.2012.09.026. Epub 2012 Oct 17.

PMID:
23085307
5.

Alphavirus antiviral drug development: scientific gap analysis and prospective research areas.

Reichert E, Clase A, Bacetty A, Larsen J.

Biosecur Bioterror. 2009 Dec;7(4):413-27. doi: 10.1089/bsp.2009.0032. Review.

PMID:
20028250
6.

Venezuelan and western equine encephalitis virus E1 liposome antigen nucleic acid complexes protect mice from lethal challenge with multiple alphaviruses.

Rico AB, Phillips AT, Schountz T, Jarvis DL, Tjalkens RB, Powers AM, Olson KE.

Virology. 2016 Dec;499:30-39. doi: 10.1016/j.virol.2016.08.023. Epub 2016 Sep 12.

PMID:
27632563
7.

The ubiquitin proteasome system plays a role in venezuelan equine encephalitis virus infection.

Amaya M, Keck F, Lindquist M, Voss K, Scavone L, Kehn-Hall K, Roberts B, Bailey C, Schmaljohn C, Narayanan A.

PLoS One. 2015 Apr 30;10(4):e0124792. doi: 10.1371/journal.pone.0124792. eCollection 2015.

8.

Directed molecular evolution improves the immunogenicity and protective efficacy of a Venezuelan equine encephalitis virus DNA vaccine.

Dupuy LC, Locher CP, Paidhungat M, Richards MJ, Lind CM, Bakken R, Parker MD, Whalen RG, Schmaljohn CS.

Vaccine. 2009 Jun 24;27(31):4152-60. doi: 10.1016/j.vaccine.2009.04.049. Epub 2009 May 9.

PMID:
19406186
9.

A Quantitative Real-Time RT-PCR Assay for the Detection of Venezuelan equine encephalitis virus Utilizing a Universal Alphavirus Control RNA.

Vina-Rodriguez A, Eiden M, Keller M, Hinrichs W, Groschup MH.

Biomed Res Int. 2016;2016:8543204. doi: 10.1155/2016/8543204. Epub 2016 Nov 29.

10.

Ablation of Programmed -1 Ribosomal Frameshifting in Venezuelan Equine Encephalitis Virus Results in Attenuated Neuropathogenicity.

Kendra JA, de la Fuente C, Brahms A, Woodson C, Bell TM, Chen B, Khan YA, Jacobs JL, Kehn-Hall K, Dinman JD.

J Virol. 2017 Jan 18;91(3). pii: e01766-16. doi: 10.1128/JVI.01766-16. Print 2017 Feb 1.

11.

Seroepidemiology of selected alphaviruses and flaviviruses in bats in Trinidad.

Thompson NN, Auguste AJ, Travassos da Rosa AP, Carrington CV, Blitvich BJ, Chadee DD, Tesh RB, Weaver SC, Adesiyun AA.

Zoonoses Public Health. 2015 Feb;62(1):53-60. doi: 10.1111/zph.12118. Epub 2014 Apr 17.

PMID:
24751420
13.

Epidemiology of Emergent Madariaga Encephalitis in a Region with Endemic Venezuelan Equine Encephalitis: Initial Host Studies and Human Cross-Sectional Study in Darien, Panama.

Vittor AY, Armien B, Gonzalez P, Carrera JP, Dominguez C, Valderrama A, Glass GE, Beltran D, Cisneros J, Wang E, Castillo A, Moreno B, Weaver SC.

PLoS Negl Trop Dis. 2016 Apr 21;10(4):e0004554. doi: 10.1371/journal.pntd.0004554. eCollection 2016 Apr.

14.
15.

Development of human antibody fragments using antibody phage display for the detection and diagnosis of Venezuelan equine encephalitis virus (VEEV).

Kirsch MI, Hülseweh B, Nacke C, Rülker T, Schirrmann T, Marschall HJ, Hust M, Dübel S.

BMC Biotechnol. 2008 Sep 2;8:66. doi: 10.1186/1472-6750-8-66.

16.

Development of a Real-Time Cell Analysing (RTCA) method as a fast and accurate screen for the selection of chikungunya virus replication inhibitors.

Marlina S, Shu MH, AbuBakar S, Zandi K.

Parasit Vectors. 2015 Nov 9;8:579. doi: 10.1186/s13071-015-1104-y.

17.

Inhibitors of alphavirus entry and replication identified with a stable Chikungunya replicon cell line and virus-based assays.

Pohjala L, Utt A, Varjak M, Lulla A, Merits A, Ahola T, Tammela P.

PLoS One. 2011;6(12):e28923. doi: 10.1371/journal.pone.0028923. Epub 2011 Dec 19.

18.

Small molecule inhibitors of Ago2 decrease Venezuelan equine encephalitis virus replication.

Madsen C, Hooper I, Lundberg L, Shafagati N, Johnson A, Senina S, de la Fuente C, Hoover LI, Fredricksen BL, Dinman J, Jacobs JL, Kehn-Hall K.

Antiviral Res. 2014 Dec;112:26-37. doi: 10.1016/j.antiviral.2014.10.002. Epub 2014 Oct 18.

PMID:
25448087
19.

Immunologic interference from sequential administration of live attenuated alphavirus vaccines.

McClain DJ, Pittman PR, Ramsburg HH, Nelson GO, Rossi CA, Mangiafico JA, Schmaljohn AL, Malinoski FJ.

J Infect Dis. 1998 Mar;177(3):634-41.

PMID:
9498442
20.

Genus-specific detection of alphaviruses by a semi-nested reverse transcription-polymerase chain reaction.

Pfeffer M, Proebster B, Kinney RM, Kaaden OR.

Am J Trop Med Hyg. 1997 Dec;57(6):709-18.

PMID:
9430533

Supplemental Content

Support Center